NAGE vs VTI
Niagen Bioscience, Inc. (NAGE) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
VTI does not have a complete income-statement cache yet.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. VTI currently screens at market cap $0.
Not investment advice. Open the NAGE and VTI stock pages for the full models.
Not investment advice.